The 20 Best Chronic Antibody-Mediated Rejection Doctors Near Me in San Francisco, CA

William Bry is a General Surgeon practicing medicine in San Francisco, California. Dr. Bry is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Bry is board certified in Surgery - Board Certified.

Harish Mahanty is a General Surgeon practicing medicine in San Francisco, California. Dr. Mahanty is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Hernia, Fibrolamellar Carcinoma, Simultaneous Pancreas Kidney Transplant, and Kidney Transplant. Dr. Mahanty is board certified in Surgery - Board Certified. Dr. Mahanty is currently accepting new patients.

Janet Bellingham is a General Surgeon practicing medicine in San Francisco, California. Dr. Bellingham is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Chronic Antibody-Mediated Rejection, Gastroparesis, Polycystic Kidney Disease, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Bellingham is board certified in Surgery - Board Certified. Dr. Bellingham is currently accepting new patients.

Eric Miller is a Urologist practicing medicine in San Francisco, California. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Simultaneous Pancreas Kidney Transplant, and Kidney Transplant. Dr. Miller is currently accepting new patients.

Assad Hassoun is a General Surgeon practicing medicine in San Francisco, California. Dr. Hassoun is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Hepatectomy. Dr. Hassoun is board certified in Surgery - Board Certified. Dr. Hassoun is currently accepting new patients.

Dr. Charles M. Eichler is a specialist in both traditional and endovascular surgery. He has devoted his career to performing complex operations involving all aspects of arterial circulation, including surgery of the aorta, carotid arteries and lower extremities. He has extensive experience in lower extremity reconstruction for both claudication (impaired gait from obstructed arteries) and limb-threatening ischemia (limited blood flow). He is recognized as an expert in hemodialysis access surgery, a minimally invasive procedure to create a passageway that will facilitate dialysis treatments. Eichler earned his medical degree from St. Louis University in 1978. He completed his residency in general surgery at UCSF, followed by a fellowship in peripheral vascular surgery. He also completed a fellowship in endovascular surgery at Texas Tech University. Dr. Eichler is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Thoracic Aortic Aneurysm, Carotid Artery Disease, Peripheral Artery Disease, Osteotomy, and Carotid Artery Surgery. Dr. Eichler is board certified in American Board Of Surgery, General Surgery. Dr. Eichler is currently accepting new patients.

Michael Hong is a General Surgeon practicing medicine in San Francisco, California. Dr. Hong is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Deep Vein Thrombosis, Gangrene, Arterial Embolism, Carotid Artery Surgery, and Gastrostomy. Dr. Hong is board certified in Surgery General Surgery and Surgery Vascular Surgery. Dr. Hong is currently accepting new patients.

Dr. Christopher E. Freise is an organ transplant surgeon with particular interests in adult and pediatric liver and kidney transplants, surgery for liver tumors and kidney cysts, laparoscopic surgery for the liver and gallbladder, and surgery for dialysis access. In his research, Freise studies immunosuppressive drugs used after transplantation and methods to prevent the tissue injury that occurs after blood supply is restored to the organ. His research is recognized and funded by the National Institutes of Health and American Society of Transplant Surgeons. Freise earned his medical degree at the University of Minnesota, where he completed a residency in surgery. He completed a postdoctoral fellowship in transplant surgery at UCSF. He is a fellow of the American College of Surgeons. Dr. Freise is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), SVC Obstruction, May Thurner Syndrome, Liver Transplant, and Kidney Transplant. Dr. Freise is board certified in American Board Of Surgery, General Surgery. Dr. Freise is currently accepting new patients.

Ryutaro Hirose is a Nephrologist practicing medicine in San Francisco, California. Dr. Hirose is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Liver Cancer, Chronic Antibody-Mediated Rejection, Kidney Transplant, and Liver Transplant.

Dr. Garrett R. Roll is a general surgeon who specializes in abdominal organ transplantation. He cares for both adults and children, performing liver and kidney transplants using living donors; complex procedures involving the liver, pancreas, gallbladder and bile ducts; and kidney autotransplants (removing a diseased kidney to treat a challenging problem with the ureter, then placing the kidney back into the patient). He also provides surgical care for patients with end-stage organ disease and patients on immunosuppressive therapies. His expertise includes using minimally invasive techniques. Roll is an investigator on clinical trials looking at outcomes for organ transplant recipients and at advanced organ preservation (storing organs for future transplantation). He serves in leadership roles for several patient safety and quality improvement committees at UCSF, in addition to teaching medical students and residents. He is also on the editorial board of multiple peer-reviewed journals. Roll earned his medical degree from the Lewis Katz School of Medicine at Temple University. He completed a residency in general surgery and a fellowship in abdominal transplant surgery at UCSF, while also studying liver cell therapy and liver regeneration in Dr. Holger Willenbring's laboratory. After completing his training, he was a senior international fellow in liver retrieval and transplant at Queen Elizabeth Hospital Birmingham, which has the busiest liver surgery unit in the United Kingdom. During this time, he gained experience with donation after circulatory death (DCD) liver transplantation and a method of preserving donated livers during transport called normothermic machine perfusion. Dr. Roll is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Liver Cancer, Mesenteric Venous Thrombosis, Liver Transplant, and Kidney Transplant. Dr. Roll is board certified in American Board Of Internal Medicine, Surgery. Dr. Roll is currently accepting new patients.

Dr. Sang-Mo Kang is an organ transplant surgeon, performing transplants of the kidney, liver and pancreas. His expertise includes gastrointestinal surgery, laparoscopic kidney donor surgery, laparoscopic liver surgery, and surgeries related to the liver, bile ducts and gallbladder. Kang maintains a research laboratory focused on understanding how the immune system responds to transplanted organs. He investigates new methods to induce transplant-specific tolerance, with the goal of replacing immunosuppressive medications. He has been awarded research grants from the National Institutes of Health (NIH) and American Society of Transplant Surgeons. Kang earned his medical degree at Harvard Medical School and completed a surgical residency and transplant fellowship at UCSF Medical Center. He received two research fellowships from the Howard Hughes Medical Institute, which he used to study transplant immunology at the NIH and the UCSF Transplantation Research Laboratory. Kang teaches fellows, residents and medical students at UCSF. Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Gastroparesis, Chronic Antibody-Mediated Rejection, Fibrolamellar Carcinoma, Liver Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Kang is board certified in American Board Of Surgery, General Surgery. Dr. Kang is currently accepting new patients.

Dr. Shareef Syed is a general surgeon who specializes in abdominal organ transplantation. His training includes kidney and liver transplantation for both adults and children, and laparoscopic donor nephrectomy, a minimally invasive procedure for transferring a kidney from a living donor to a recipient. He also has expertise in minimally invasive procedures to address conditions of the kidneys, liver and bile ducts – the channels that transport digestive fluid made by the liver. Syed's research explores outcomes for liver and kidney transplant patients, with special attention to those who have hepatocellular carcinoma, a common form of liver cancer. He is currently studying the impact of long wait-list times and local-regional therapies on the outcomes of patients with liver cancer who undergo transplantation. He is also studying novel noninvasive tests to detect impending kidney rejection. He enjoys teaching medical students, residents in general surgery and abdominal transplant fellows. After earning his medical degree at the University of Leicester, Syed completed three years of medical and surgical residency with the National Health Service in England. He trained in internal medicine and surgery at the University of Southampton and cardiothoracic surgery at the University of Bristol. During this time, he qualified for admission to the Royal College of Surgeons. He then started residency in general surgery at Central Michigan University and completed it at the UCSF, followed by a fellowship in abdominal transplantation at UCSF. Syed is a member of numerous professional organizations, including the American Society of Transplant Surgeons, American College of Surgeons, American Association for the Study of Liver Diseases, American Society of Transplantation and Americas Hepato-Pancreato-Biliary Association. Dr. Syed is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Fibrolamellar Carcinoma, Chronic Antibody-Mediated Rejection, Liver Transplant, and Kidney Transplant. Dr. Syed is board certified in American Board Of Surgery, General Surgery. Dr. Syed is currently accepting new patients.

Dr. Andrew Posselt, a bariatric and transplant surgeon, is co-director of the Pancreatic Islet Transplantation Program at UCSF Medical Center. He specializes in adult and pediatric kidney, liver and pancreas transplantation, as well as laparoscopic and open (traditional) bariatric surgery. In addition to caring for patients, Posselt conducts research on pancreatic islet cell transplantation, a procedure that can allow people with type 1 diabetes to discontinue insulin therapy. He also investigates mechanisms by which a transplant recipient's body rejects or tolerates tissue from a donor who isn't genetically identical, and he studies the metabolic and biochemical consequences of bariatric surgery. Posselt earned his medical degree and a doctorate in immunology from the University of Pennsylvania. He completed residencies in internal medicine and general surgery as well as a transplant fellowship at UCSF, before joining the staff in 2003. Posselt is a member of several professional and honorary societies, and has given presentations on transplant issues related to patient care and research. At UCSF, he supervises residents and fellows in transplant services and general surgery. Dr. Posselt is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Obesity, Chronic Pancreatitis, Childhood Pancreatitis, Islet Cell Transplantation, and Sleeve Gastrectomy. Dr. Posselt is board certified in American Board Of Surgery, General Surgery. Dr. Posselt is currently accepting new patients.

Dr. Peter Stock is a transplant surgeon who specializes in kidney, liver and pancreas transplants. He is co-director of the Pancreatic Islet Cell Transplantation Program. In his research, Stock studies body mechanisms that lead to transplant rejection when the donor and recipient are not genetically identical. He also studies chimerism (a therapy to prevent transplant rejection that uses the donor's bone marrow cells) and pancreatic islet cell transplantation (a procedure that can allow people with type 1 diabetes to discontinue insulin therapy). Stock received his medical training at the University of Minnesota, completing a surgical residency before coming to UCSF for a transplant fellowship. He joined the UCSF faculty in 1992. Stock is an active teacher and supervises surgical residents and fellows. He is a member of numerous professional and honorary societies. Dr. Stock is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Fibrolamellar Carcinoma, Simultaneous Pancreas Kidney Transplant, and Kidney Transplant. Dr. Stock is board certified in American Board Of Surgery, General Surgery. Dr. Stock is currently accepting new patients.

Dr. Nancy Ascher has devoted her career to organ transplantation and transplant research. She has served on the Presidential Task Force on Organ Transplantation, Surgeon General's Task Force on Increasing Donor Organs and Secretary of Health and Human Services Advisory Committee on Organ Transplantation. Ascher is a graduate of the University of Michigan, Ann Arbor, where she earned her medical degree. She completed a general surgery residency and clinical transplant fellowship at the University of Minnesota, where she later joined the faculty and became clinical director of the liver transplant program. Ascher is a fellow of the American College of Surgeons. She is a member of numerous other medical societies, including the American Society of Transplant Surgeons, in which she has served as president. Dr. Ascher is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Liver Failure, Fibrolamellar Carcinoma, Hepatitis, Liver Transplant, and Kidney Transplant. Dr. Ascher is board certified in American Board Of Surgery, General Surgery and American Board Of Medical Specialties, General Surgery. Dr. Ascher is currently accepting new patients.

John Roberts is a Transplant Surgeon practicing medicine in San Francisco, California. Dr. Roberts is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Liver Failure, Fibrolamellar Carcinoma, Liver Transplant, and Kidney Transplant.

Sandy Feng is a General Surgeon practicing medicine in San Francisco, California. Dr. Feng is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Hepatitis, Autoimmune Hepatitis, Liver Failure, Liver Transplant, and Kidney Transplant.

Seiji Yamaguchi is a General Surgeon practicing medicine in San Francisco, California. Dr. Yamaguchi is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Glutaric Acidemia Type 2, Beta-Ketothiolase Deficiency, Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome), Kidney Transplant, and Nephrectomy.